This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Jan 16;382(3):289-290.

doi: 10.1056/NEJMe1916598.

Difelikefalin for the Treatment of Uremic Pruritus

David J R Steele¹

Affiliations

PMID: 31940704
DOI: 10.1056/NEJMe1916598

Editorial

Difelikefalin for the Treatment of Uremic Pruritus

David J R Steele. N Engl J Med. 2020.

. 2020 Jan 16;382(3):289-290.

doi: 10.1056/NEJMe1916598.

Author

David J R Steele¹

Affiliation

¹ From Massachusetts General Hospital, Boston.

PMID: 31940704
DOI: 10.1056/NEJMe1916598

No abstract available

PubMed Disclaimer

Comment in

Difelikefalin in Hemodialysis Patients with Pruritus.
Brennan F, Davison S, Brown M. Brennan F, et al. N Engl J Med. 2020 May 21;382(21):2064. doi: 10.1056/NEJMc2002485. N Engl J Med. 2020. PMID: 32433845 No abstract available.
Difelikefalin in Hemodialysis Patients with Pruritus.
Manenti L, Rossi GM, Fiaccadori E. Manenti L, et al. N Engl J Med. 2020 May 21;382(21):2064. doi: 10.1056/NEJMc2002485. N Engl J Med. 2020. PMID: 32433846 No abstract available.
Difelikefalin in Hemodialysis Patients with Pruritus.
Lin CH. Lin CH. N Engl J Med. 2020 May 21;382(21):2064-2065. doi: 10.1056/NEJMc2002485. N Engl J Med. 2020. PMID: 32433847 No abstract available.

Comment on

A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F; KALM-1 Trial Investigators. Fishbane S, et al. N Engl J Med. 2020 Jan 16;382(3):222-232. doi: 10.1056/NEJMoa1912770. Epub 2019 Nov 8. N Engl J Med. 2020. PMID: 31702883 Clinical Trial.

Similar articles

Recent advances in the treatment of uremic pruritus.
Trachtenberg AJ, Collister D, Rigatto C. Trachtenberg AJ, et al. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):465-470. doi: 10.1097/MNH.0000000000000625. Curr Opin Nephrol Hypertens. 2020. PMID: 32740217 Review.
Newer and Safer Kappa-Opioid Agonist for Your Patients With Uremic Pruritus.
Lagacé F, Jfri A, Litvinov IV, Netchiporouk E. Lagacé F, et al. J Cutan Med Surg. 2020 Sep/Oct;24(5):525-526. doi: 10.1177/1203475420926989. Epub 2020 May 19. J Cutan Med Surg. 2020. PMID: 32426990 No abstract available.
Difelikefalin in Hemodialysis Patients with Pruritus. Reply.
Fishbane S. Fishbane S. N Engl J Med. 2020 May 21;382(21):2065-2066. doi: 10.1056/NEJMc2002485. N Engl J Med. 2020. PMID: 32433848 No abstract available.
Difelikefalin in Hemodialysis Patients with Pruritus.
Lin CH. Lin CH. N Engl J Med. 2020 May 21;382(21):2064-2065. doi: 10.1056/NEJMc2002485. N Engl J Med. 2020. PMID: 32433847 No abstract available.
Treatment of Uremic Pruritus: A Systematic Review.
Simonsen E, Komenda P, Lerner B, Askin N, Bohm C, Shaw J, Tangri N, Rigatto C. Simonsen E, et al. Am J Kidney Dis. 2017 Nov;70(5):638-655. doi: 10.1053/j.ajkd.2017.05.018. Epub 2017 Jul 15. Am J Kidney Dis. 2017. PMID: 28720208 Review.

See all similar articles

Cited by

Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch.
Wang X, Gou X, Yu X, Bai D, Tan B, Cao P, Qian M, Zheng X, Wang H, Tang P, Zhang C, Ye F, Ni J. Wang X, et al. Front Pharmacol. 2021 Nov 16;12:773204. doi: 10.3389/fphar.2021.773204. eCollection 2021. Front Pharmacol. 2021. PMID: 34867403 Free PMC article.
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments.
Vander Does A, Levy C, Yosipovitch G. Vander Does A, et al. Am J Clin Dermatol. 2022 Sep;23(5):647-659. doi: 10.1007/s40257-022-00710-2. Epub 2022 Jul 28. Am J Clin Dermatol. 2022. PMID: 35900649 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information